MUMBAI, India Oct. 23, 2024 /CNW/ -- Piramal Pharma Limited (NSE:PPLPHARMA) (BSE:543635), a leading global pharmaceuticals and wellness company, today announced its standalone and consolidated results for the Second Quarter (Q2) and Half Year (H1) ended 30th September 2024.
Read more at newswire.caPiramal Pharma Limited Announces Results for Q2 and H1 FY25
Newswire.ca - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here